PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Lingkun Zhao

Tianjin Medical University Cancer Institute and Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

SLC3A2 identified as a new therapeutic target for head and neck squamous cell carcinoma

BMC Cancer

Mechanistic, exploratory study identifying a candidate gene target through bioinformatic screening and uncontrolled in vitro experiments without clinical validation or efficacy data in human disease.

Hypothesis-GeneratingEndoplasmic Reticulum Stress and Disease Rui Li Lingkun Zhao

Study details

DesignBioinformatic screening with in vitro cell…

InterventionSLC3A2 overexpression, SLC3A2 knockdown, RI…

ComparatorBaseline or control cell conditions (specif…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support